เอกสารอ้างอิง
[1] American pharmacists association. Drug information handbook with international trade names index. 25th edition. United States: Wolters Kluwer Clinical drug information; 2016. p1171.
[2] Kian CH, Pascual RD, Legaspi CD, Pico GM. MIMS PHARMACY patient counselling guide thailand. 19th edition.: UNISON; 2019. p119.
[3] สุรเกียรติ อาชานานุภาพ. ตำราการตรวจรักษาโรคทั่วไป หลักการวินิจฉัยและรักษาโรค/280 โรคและการดูแลรักษา. กรุงเทพ: พิมพ์ดี; 2544. 611-3.
[4] Brunton LL, Chabner BA, Knollmann BC. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th edition. New York: McGraw-Hill; 2011.p1787.
[5] McEvoy GK, editor. AHFS drug information 2014. Bethedsa (MD): American Society of Health-System Pharmacists; 2014.p2942-6.
[6] Fogagnolo, P., Dipinto, A., Vanzulli, E., Maggiolo, E., De Cilla', S., Autelitano, A., & Rossetti, L. A 1-year randomized study of the clinical and confocal effects of tafluprost and latanoprost in newly diagnosed glaucoma patients.” Advances in therapy .2015;32(4): 356-69.
[7] Park SH, Yoo SH, Ha SJ. Comparison of Ocular Pulse Amplitude-Lowering Effects of Tafluprost and Latanoprost by Dynamic Contour Tonometry. J Ocul Pharmacol Ther. 2015;31(10):617-22.
[8] Wong TT, Aung T, Ho CL. Ocular surface status in glaucoma and ocular hypertension patients with existing corneal disorders switched from latanoprost 0.005% to tafluprost 0.0015%: comparison of two prostaglandin analogues with different concentrations of benzalkonium chloride. Clin Exp Ophthalmol. 2018;46(9):1028-1034.
[9] Latanoprost. In: MIMS Online [database on the Internet]. MIMS Thailand; 2019 [cited October 30, 2019]. Available from: https://www.mims.com/thailand/drug/search?q=Latanoprost.
[10] Tafluprost. In: MIMS Online [database on the Internet]. MIMS Thailand; 2019 [cited October 30, 2019]. Available from: https://www.mims.com/thailand/drug/search?q=Tafluprost.